Botulinum toxin A injections do not improve surface EMG patterns during gait in children with cerebral palsy-A randomized controlled study

Gait and Posture

Volumn 33, Issue 2, 2011, Pages 147-151

  van der Houwen, L E E ^a   Scholtes, V A ^a   Becher, J G ^a   Harlaar, J ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Cerebral palsy; Multilevel BTX A; Surface EMG

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTROMYOGRAM; FEMALE; GAIT; GASTROCNEMIUS MUSCLE; HAMSTRING; HUMAN; KINEMATICS; KNEE FUNCTION; LEG MUSCLE; MALE; MOTOR CONTROL; MULTICENTER STUDY; MUSCLE CONTRACTION; MUSCLE FUNCTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTUS FEMORIS MUSCLE; SCHOOL CHILD; SURFACE ELECTROMYOGRAM; THERAPY EFFECT; TREATMENT FAILURE; VIDEORECORDING; WALKING; WALKING DIFFICULTY;

BOTULINUM TOXINS, TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; ELECTROMYOGRAPHY; FEMALE; GAIT; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; VIDEO RECORDING;

EID: 79951551187     PISSN: 09666362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gaitpost.2010.11.001     Document Type: Article

References (36)

1. Rosenbaum P., Paneth N., Leviton A., Goldstein M., Bax M., Damiano D., et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol 2007, 109(Suppl.):8-14.
2. Beckung E., Carlsson G., Carlsdotter S., Uvebrant P. The natural history of gross motor development in children with cerebral palsy aged 1 to 15 years. Dev Med Child Neurol 2007, 49:751-756.
3. Becher J.G. Pediatric rehabilitation in children with cerebral palsy: general management, classification of motor disorders. J Prosthet Orthot 2002, 14:143-149.
4. Gage J.R. The treatment of gait problems in cerebral palsy 2004, Mac Keith Press, London (UK).
5. Gannotti M., Gorton G.E., Nahorniak M.T., Gagnaire N., Fil A., Hogue J., et al. Changes in gait velocity, mean knee flexion in stance, body mass index, and popliteal angle with age in ambulatory children with cerebral palsy. J Pediatr Orthop 2008, 28:103-111.
6. Voorman J.M., Dallmeijer A.J., Knol D.L., Lankhorst G.J., Becher J.G. Prospective longitudinal study of gross motor function in children with cerebral palsy. Arch Phys Med Rehabil 2007, 88:871-876.
7. Scholtes V.A., Dallmeijer A.J., Knol D.L., Speth L.A., Maathuis C.G., Jongerius P.H., et al. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy. Pediatr Neurol 2007, 36:30-39.
8. Nolan K.W., Cole L.L., Liptak G.S. Use of botulinum toxin type A in children with cerebral palsy. Phys Ther 2006, 86:573-584.
9. Cosgrove A.P., Graham H.K. Botulinum toxin A prevents the development of contractures in the hereditary spastic mouse. Dev Med Child Neurol 1994, 36:379-385.
10. Scholtes V.A., Dallmeijer A.J., Knol D.L., Speth L.A., Maathuis C.G., Jongerius P.H., et al. The combined effect of lower-limb multilevel botulinum toxin type a and comprehensive rehabilitation on mobility in children with cerebral palsy: a randomized clinical trial. Arch Phys Med Rehabil 2006, 87:1551-1558.
11. Brunt D., Scarborough N. Ankle muscle activity during gait in children with cerebral palsy and equinovarus deformity. Arch Phys Med Rehabil 1988, 69:115-117.
12. Csongradi J., Bleck E., Ford W.F. Gait electromyography in normal and spastic children, with special reference to quadriceps femoris and hamstring muscles. Dev Med Child Neurol 1979, 21:738-748.
13. Granata K.P., Padua D.A., Abel M.F. Repeatability of surface EMG during gait in children. Gait Posture 2005, 22:346-350.
14. Kleissen R., Litjens M., Baten C., Harlaar J., Hof A., Zilvold G. Consistency of surface EMG patterns obtained during gait from three laboratories using standardised measurement technique. Gait Posture 1997, 6:200-209.
15. Farina D., Cescon C., Merletti R. Influence of anatomical, physical, and detection-system parameters on surface EMG. Biol Cybern 2002, 86:445-456.
16. Hof A.L., Elzinga H., Grimmius W., Halbertsma J.P. Detection of non-standard EMG profiles in walking. Gait Posture 2005, 21:171-177.
17. Bottos M., Benedetti M.G., Salucci P., Gasparroni V., Giannini S. Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment. Dev Med Child Neurol 2003, 45:758-762.
18. Desloovere K., Molenaers G., Jonkers I., De Cat J., De Borre L., Nijs J., et al. A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures. Eur J Neurol 2001, 8(Suppl. 5):75-87.
19. Detrembleur C., Lejeune T.M., Renders A., Van den Bergh P.Y. Botulinum toxin and short-term electrical stimulation in the treatment of equinus in cerebral palsy. Mov Disord 2002, 17:162-169.
20. Hesse S., Brandl-Hesse B., Seidel U., Doll B., Gregoric M. Lower limb muscle activity in ambulatory children with cerebral palsy before and after the treatment with Botulinum toxin A. Restor Neurol Neurosci 2000, 17:1-8.
21. Manganotti P., Zaina F., Falso M., Milanese F., Fiaschi A. Evaluation of botulinum toxin therapy of spastic equinus in paediatric patients with cerebral palsy. J Rehabil Med 2007, 39:115-120.
22. Mousny M., Allington N. Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study. Rev Chir Orthop Reparatrice Appar Mot 1999, 85:156-163.
23. Sutherland D.H., Kaufman K.R., Wyatt M.P., Chambers H.G. Injection of botulinum A toxin into the gastrocnemius muscle of patients with cerebral palsy: a 3-dimensional motion analysis study. Gait Posture 1996, 4:269-279.
24. Sutherland D.H., Kaufman K.R., Wyatt M.P., Chambers H.G., Mubarak S.J. Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture 1999, 10:1-9.
25. Hagberg B. Clinical syndromes in cerebral palsy: an extensive neuropediatric study. Monatsschr Kinderheilkd 1973, 121:259-264.
26. Palisano R., Rosenbaum P., Walter S., Russell D., Wood E., Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997, 39:214-223.
27. Reimers J. The stability of the hip in children. A radiological study of the results of muscle surgery in cerebral palsy. Acta Orthop Scand 1980, 184(Suppl.):1-100.
28. Hermens H.J., Freriks B., Disselhorst-Klug C., Rau G. Development of recommendations for SEMG sensors and sensor placement procedures. J Electromyogr Kinesiol 2000, 10:361-374.
29. Harlaar J., Redmeijer R.A., Tump P., Peters R., Hautus E. The SYBAR system: integrated recording and display of video, EMG, and force plate data. Behav Res Methods Instrum Comput 2000, 32:11-16.
30. Hof A.L., Elzinga H., Grimmius W., Halbertsma J.P. Speed dependence of averaged EMG profiles in walking. Gait Posture 2002, 16:78-86.
31. Romkes J., Brunner R. An electromyographic analysis of obligatory (hemiplegic cerebral palsy) and voluntary (normal) unilateral toe-walking. Gait Posture 2007, 26:577-586.
32. Sutherland D.H., Olshen R., Cooper L., Woo S.L. The development of mature gait. J Bone Joint SurgAm 1980, 62:336-353.
33. Berger W., Quintern J., Dietz V. Pathophysiology of gait in children with cerebral palsy. Electroencephalogr Clin Neurophysiol 1982, 53:538-548.
34. van der Krogt M.M., Doorenbosch C.A., Becher J.G., Harlaar J. Dynamic spasticity of plantar flexor muscles in cerebral palsy gait. J Rehabil Med. 2010, 42(July(7)):656-663.
35. Cosgrove A.P., Corry I.S., Graham H.K. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994, 36:386-396.
36. Ibrahim A.I., Hawamdeh Z.M., Al-Qudah A.A. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children. Eura Medicophys 2007, 43:13-20.